Poelhekken, Keris
Dorrius, Monique D.
Dibden, Amanda
Duffy, Stephen W.
van der Vegt, Bert
de Bock, Geertruida H.
Greuter, Marcel J. W.
Article History
Received: 13 September 2024
Accepted: 4 February 2025
First Online: 1 March 2025
Declarations
:
: The authors declare the following financial interests / personal relationships which may be considered as potential competing interests: BvdV reports honoraria received by UMCG for expertise or scientific advisory board/consultancy (on request) for Visiopharm, Philips, MSD/Merck, Daiichi-Sankyo/AstraZenica; Speaker’s fee from Visiopharm, Diaceutics, MSD/Merck; Research grants from OWKIN and GE Healthcare; Personal fees from DEKRA. All honoraria to UMCG. All unrelated to the current manuscript.
: This study used publicly available anonymized data, thus was exempt from ethical compliance (IRB approval M24.331461, Medical Ethics Review Board Groningen, The Netherlands).